151 related articles for article (PubMed ID: 11940704)
21. Safety and efficacy of Gliadel wafers for newly diagnosed and recurrent glioblastoma.
De Bonis P; Anile C; Pompucci A; Fiorentino A; Balducci M; Chiesa S; Maira G; Mangiola A
Acta Neurochir (Wien); 2012 Aug; 154(8):1371-8. PubMed ID: 22718138
[TBL] [Abstract][Full Text] [Related]
22. Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma.
Rampling R; Cruickshank G; Papanastassiou V; Nicoll J; Hadley D; Brennan D; Petty R; MacLean A; Harland J; McKie E; Mabbs R; Brown M
Gene Ther; 2000 May; 7(10):859-66. PubMed ID: 10845724
[TBL] [Abstract][Full Text] [Related]
23. Overcoming therapeutic resistance in glioblastoma: the way forward.
Osuka S; Van Meir EG
J Clin Invest; 2017 Feb; 127(2):415-426. PubMed ID: 28145904
[TBL] [Abstract][Full Text] [Related]
24. Tissue Hypoxia and Alterations in Microvascular Architecture Predict Glioblastoma Recurrence in Humans.
Stadlbauer A; Kinfe TM; Eyüpoglu I; Zimmermann M; Kitzwögerer M; Podar K; Buchfelder M; Heinz G; Oberndorfer S; Marhold F
Clin Cancer Res; 2021 Mar; 27(6):1641-1649. PubMed ID: 33293375
[TBL] [Abstract][Full Text] [Related]
25. Tumour Treating Fields (TTFs) for recurrent and newly diagnosed glioblastoma multiforme.
Mirza FA; Shamim MS
J Pak Med Assoc; 2018 Oct; 68(10):1543-1545. PubMed ID: 30317361
[TBL] [Abstract][Full Text] [Related]
26. From imaging to biology of glioblastoma: new clinical oncology perspectives to the problem of local recurrence.
Zygogianni A; Protopapa M; Kougioumtzopoulou A; Simopoulou F; Nikoloudi S; Kouloulias V
Clin Transl Oncol; 2018 Aug; 20(8):989-1003. PubMed ID: 29335830
[TBL] [Abstract][Full Text] [Related]
27. Clinical benefit in recurrent glioblastoma from adjuvant NovoTTF-100A and TCCC after temozolomide and bevacizumab failure: a preliminary observation.
Wong ET; Lok E; Swanson KD
Cancer Med; 2015 Mar; 4(3):383-91. PubMed ID: 25620708
[TBL] [Abstract][Full Text] [Related]
28. Re-irradiation after gross total resection of recurrent glioblastoma : Spatial pattern of recurrence and a review of the literature as a basis for target volume definition.
Straube C; Elpula G; Gempt J; Gerhardt J; Bette S; Zimmer C; Schmidt-Graf F; Meyer B; Combs SE
Strahlenther Onkol; 2017 Nov; 193(11):897-909. PubMed ID: 28616821
[TBL] [Abstract][Full Text] [Related]
29. Expression of EGFR in Paired New and Recurrent Glioblastomas.
Cioca A; Olteanu EG; Gisca MD; Morosanu CO; Marin I; Florian IS
Asian Pac J Cancer Prev; 2016; 17(9):4205-4208. PubMed ID: 27797218
[TBL] [Abstract][Full Text] [Related]
30. Initial evidence that blood-borne microvesicles are biomarkers for recurrence and survival in newly diagnosed glioblastoma patients.
Evans SM; Putt M; Yang XY; Lustig RA; Martinez-Lage M; Williams D; Desai A; Wolf R; Brem S; Koch CJ
J Neurooncol; 2016 Apr; 127(2):391-400. PubMed ID: 26746692
[TBL] [Abstract][Full Text] [Related]
31. Laser interstitial thermal therapy for newly diagnosed and recurrent glioblastoma.
Thomas JG; Rao G; Kew Y; Prabhu SS
Neurosurg Focus; 2016 Oct; 41(4):E12. PubMed ID: 27690657
[TBL] [Abstract][Full Text] [Related]
32. Immunogene therapy of recurrent glioblastoma multiforme with a liposomally encapsulated replication-incompetent Semliki forest virus vector carrying the human interleukin-12 gene--a phase I/II clinical protocol.
Ren H; Boulikas T; Lundstrom K; Söling A; Warnke PC; Rainov NG
J Neurooncol; 2003; 64(1-2):147-54. PubMed ID: 12952295
[TBL] [Abstract][Full Text] [Related]
33. A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group.
Shand N; Weber F; Mariani L; Bernstein M; Gianella-Borradori A; Long Z; Sorensen AG; Barbier N
Hum Gene Ther; 1999 Sep; 10(14):2325-35. PubMed ID: 10515452
[TBL] [Abstract][Full Text] [Related]
34. Long-term survival of patients suffering from glioblastoma multiforme treated with tumor-treating fields.
Rulseh AM; Keller J; Klener J; Sroubek J; Dbalý V; Syrůček M; Tovaryš F; Vymazal J
World J Surg Oncol; 2012 Oct; 10():220. PubMed ID: 23095807
[TBL] [Abstract][Full Text] [Related]
35. NovoTTF-100A: a new treatment modality for recurrent glioblastoma.
Fonkem E; Wong ET
Expert Rev Neurother; 2012 Aug; 12(8):895-9. PubMed ID: 22708931
[TBL] [Abstract][Full Text] [Related]
36. The role of the prolactin receptor pathway in the pathogenesis of glioblastoma: what do we know so far?
Asad AS; Nicola Candia AJ; Gonzalez N; Zuccato CF; Seilicovich A; Candolfi M
Expert Opin Ther Targets; 2020 Nov; 24(11):1121-1133. PubMed ID: 32896197
[No Abstract] [Full Text] [Related]
37. Progression-free and overall survival in patients with recurrent Glioblastoma multiforme treated with last-line bevacizumab versus bevacizumab/lomustine.
Heiland DH; Masalha W; Franco P; Machein MR; Weyerbrock A
J Neurooncol; 2016 Feb; 126(3):567-75. PubMed ID: 26614518
[TBL] [Abstract][Full Text] [Related]
38. Serial MR in gene therapy for recurrent glioblastoma: initial experience and work in progress.
Deliganis AV; Baxter AB; Berger MS; Marcus SG; Maravilla KR
AJNR Am J Neuroradiol; 1997 Sep; 18(8):1401-6. PubMed ID: 9296177
[TBL] [Abstract][Full Text] [Related]
39. Predictors of long-term survival in patients with glioblastoma multiforme: advancements from the last quarter century.
Chaudhry NS; Shah AH; Ferraro N; Snelling BM; Bregy A; Madhavan K; Komotar RJ
Cancer Invest; 2013 Jun; 31(5):287-308. PubMed ID: 23614654
[TBL] [Abstract][Full Text] [Related]
40. Clinical, Radiographic, and Pathologic Findings in Patients Undergoing Reoperation Following Radiation Therapy and Temozolomide for Newly Diagnosed Glioblastoma.
Ellsworth S; Ye X; Grossman SA
Am J Clin Oncol; 2017 Jun; 40(3):219-222. PubMed ID: 26491903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
